Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study.
Se Hyun PaekHyun Goo KimJun Woo LeeJoohyun WooHyungju KwonJong Bin KimWoosung LimJe Ryong KimByung-In MoonNam Sun PaikPublished in: Journal of breast cancer (2019)
An increase of pDCs in the peripheral blood of breast cancer patients was observed and patients with HER-2 positive breast cancer had higher levels of circulating pDCs than did HER-2 negative patients. Our results suggest that expression of DCs can differ according to breast cancer subtype and indicate that, with further investigation, DC expression has the possibility of being presented as a prognostic factor.